Get the Daily Brief
Latest Biotech News
Nuclidium Raises $99M Series B to Advance Radiopharmaceutical Manufacturing
Nuclidium AG secured CHF79 million (approximately $99.3 million) in Series B funding to tackle production and supply bottlenecks in radiopharmaceuticals. The capital will support clinical...
Proteomics Reveal Hundreds of Misfolded Proteins Linked to Cognitive Decline Beyond Amyloids
Johns Hopkins University researchers have identified over 200 misfolded proteins potentially associated with age-related cognitive decline in rats, suggesting amyloid-beta and tau proteins are not...
Partnership Boosts Real-Time Monitoring in Viral Vector and Vaccine Biomanufacturing
Univercells Technologies and Repligen have partnered to integrate real-time monitoring capabilities for glucose and lactate levels in viral vector and vaccine production. The collaboration...
Expanding Therapeutic Frontiers: Microbiota Transplants Show Promise Beyond Infections
Fecal microbiota transplantation (FMT), initially effective in treating recurrent Clostridioides difficile infections, is attracting research interest for broader applications including alopecia,...
FDA Rejects Capricor’s Cell Therapy for Duchenne Muscular Dystrophy Heart Disease
The U.S. FDA issued a Complete Response Letter to Capricor Therapeutics, citing insufficient clinical efficacy data and outstanding chemistry, manufacturing, and controls (CMC) issues for...
Biopharma Deal Volume Surges: June 2025 Hits $35B High
Biopharma dealmaking in June 2025 surged to $35.07 billion, the highest monthly total this year and among the strongest in recent history. This boost propelled first-half 2025 deal values to...
Merck’s $10 Billion Acquisition of Verona Pharma Bolsters Cardio-Pulmonary Pipeline
Merck & Co. completed a $10 billion acquisition of Verona Pharma to expand its cardio-pulmonary disease portfolio, acquiring Verona’s COPD drug and associated assets. The deal focuses on...
AI Advances Protein Dynamics Modeling for Accelerated Drug Discovery
Microsoft Research AI for Science has developed BioEmu, a generative deep learning system that models protein conformational ensembles with unprecedented speed and accuracy. Published in Science,...
New Intranasal Monoclonal Antibody Shows Efficacy Against Pollen Allergy in Mice
Researchers from Kazakh National Agrarian Research University engineered a monoclonal antibody delivered intranasally to block mugwort pollen allergens, effectively reducing hay fever and asthma...
Talent Shortage Looms Over Biomanufacturing Industry by 2028, Experts Warn
Jason Beckwith, PhD, managing director at Merrill, forecasts a biomanufacturing talent crunch emerging around 2027-28, driven by demand outpacing the supply of workers with requisite skills....
Wacker Chemie Opens New Biotech Center to Accelerate Biopharmaceutical Research
Wacker Chemie invested a multi-million euro sum to inaugurate its Biotechnology Center in Munich, consolidating biotech R&D activities focused on bioprocess development for proteins and nucleic...
Alzheimer’s Disease: Beyond Amyloids, Numerous Misfolded Proteins Identified
A Johns Hopkins University study reveals that beyond known amyloid-beta and tau plaques, over 200 additional misfolded protein types may contribute to cognitive decline linked to Alzheimer’s...
Biomanufacturing Innovation: Repligen and Univercells Integrate Real-Time Monitoring
Repligen and Univercells Technologies have partnered to embed real-time glucose and lactate monitoring within Univercells' scale-X bioreactors. The integration of Repligen’s MAVEN platform enables...
Capricor Cell Therapy Faces FDA Setback for Duchenne Muscular Dystrophy
Capricor Therapeutics received a Complete Response Letter (CRL) from the FDA regarding its deramiocel cell therapy for cardiomyopathy in Duchenne muscular dystrophy (DMD). The agency cited...
Merck Acquires Verona Pharma in $10 Billion COPD Expansion
Merck & Co. completed a $10 billion acquisition of Verona Pharma, expanding its portfolio with a fast-growing COPD treatment. The deal focuses on leveraging Verona’s lead drug, Ohtuvayre, and its...
Advanced AI Models Accelerate Protein and Genomic Research
New AI-driven technologies demonstrate significant strides in molecular biology. Microsoft's BioEmu generative deep learning model rapidly predicts protein dynamics, enabling large-scale...
Biomanufacturing Talent Crunch Looms by 2028, Experts Warn
Jason Beckwith, PhD, highlights a looming 'talent singularity' in biomanufacturing by 2028, where skilled labor demand will surpass supply due to technological advances and insufficient...
Intranasal Monoclonal Antibody Shows Promise Against Hay Fever and Asthma
Researchers at Kazakh National Agrarian Research University engineered a monoclonal antibody administered intranasally that prevents pollen-induced hay fever and asthma symptoms in mice sensitized...
Emerging Therapeutics: Circular RNA Drug Candidate and ADPKD Start-Up Launch
Shanghai Circode Biomed is initiating clinical trials for HM-2002, a circRNA-based therapeutic for ischemic heart disease with regulatory clearances in China and the US. Separately, Renasant Bio...
FDA Greenlights Cochlear’s Smart Implant and Seeks Transparency in Drug Reviews
The FDA approved Cochlear Ltd.’s Nucleus Nexa System, the first smart cochlear implant expected to launch imminently in the US, enhancing auditory device capabilities. Concurrently, FDA...